Table 4:
Subgroup analysis of the primary composite outcome (MACE and all-cause mortality) and the secondary outcome (all-cause mortality).
| Primary composite outcome (MACE + all-cause mortality) |
Secondary outcome (all-cause mortality) |
||||
|---|---|---|---|---|---|
| Subgroup | N | HR (95% CI) | P-value | HR (95% CI) | P-value |
| Sex | |||||
| Male | 560 | 1.23 (0.84; 1.82) | .29 | 1.36 (0.81; 2.28) | .24 |
| Female | 336 | 1.26 (0.80; 2.00) | .31 | 1.78 (0.94; 3.37) | .08 |
| Age | |||||
| <60 years | 428 | 1.49 (0.90; 2.47) | .12 | 1.92 (0.86; 4.26) | .11 |
| 60–70 years | 270 | 1.25 (0.72; 2.16) | .42 | 1.69 (0.83; 3.43) | .15 |
| >70 years | 198 | 1.16 (0.69; 1.96) | .57 | 1.31 (0.71; 2.45) | .39 |
| CKD stage | |||||
| 0–1 | 234 | 0.75 (0.26; 2.13) | .36 | 0.57 (0.17; 1.93) | .36 |
| 2–3 | 474 | 1.43 (0.92; 2.23) | .11 | 2.56 (1.29; 5.10) | <.01 |
| 4–5 | 188 | 1.37 (0.87; 2.15) | .42 | 1.24 (0.73; 2.08) | .42 |
| DM | |||||
| No | 747 | 1.23 (0.85; 1.77) | .27 | 1.55 (0.92; 2.59) | .10 |
| Yes | 149 | 1.33 (0.79; 2.22) | .28 | 1.50 (0.80; 2.82) | .21 |